Purple Biotech Ltd (PPBT)

Purple Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.4	14.49	15.03	10.89	11.25
Short-Term Investments	1.12	0.92	17.08	36.31	46.56
Cash & Short-Term Investments	8.52	15.41	32.11	47.2	57.81
Cash Growth	-44.69%	-52.01%	-31.96%	-18.35%	1215.24%
Accounts Receivable	-	-	-	-	0.5
Receivables	-	-	-	-	0.5
Prepaid Expenses	0.28	0.21	1	1.01	0.78
Other Current Assets	0.11	0.17	0.15	0.27	0.2
Total Current Assets	8.91	15.79	33.26	48.47	59.28
Property, Plant & Equipment	0.29	0.47	0.68	0.9	0.97
Long-Term Investments	-	-	-	0.19	-
Other Intangible Assets	27.84	28.04	20.68	20.48	20.48
Other Long-Term Assets	-	-	-	0.16	3.07
Total Assets	37.04	44.3	54.62	70.2	83.8
Accounts Payable	1.46	3.53	2.13	1.47	1.2
Accrued Expenses	1.2	3.46	4.72	2.56	1.69
Current Portion of Leases	0.18	0.19	0.19	0.2	0.21
Other Current Liabilities	1.15	2.52	0.01	0.02	-
Total Current Liabilities	3.99	9.7	7.06	4.25	3.1
Long-Term Leases	-	0.16	0.32	0.55	0.69
Total Liabilities	4.13	10.01	7.52	5.09	4.05
Additional Paid-In Capital	147.63	133.18	126.41	123.95	118.91
Retained Earnings	-144.69	-137.45	-117.57	-95.91	-77.52
Comprehensive Income & Other	29.92	38.48	38.08	36.78	38
Total Common Equity	32.86	34.21	46.91	64.83	79.39
Minority Interest	0.05	0.09	0.19	0.28	0.36
Shareholders' Equity	32.91	34.3	47.1	65.11	79.75
Total Liabilities & Equity	37.04	44.3	54.62	70.2	83.8
Total Debt	0.18	0.35	0.52	0.75	0.9
Net Cash (Debt)	8.34	15.06	31.6	46.45	56.91
Net Cash Growth	-44.62%	-52.34%	-31.98%	-18.38%	1264.09%
Net Cash Per Share	0.03	0.07	0.17	0.26	0.49
Filing Date Shares Outstanding	529.64	265.58	207.87	178.26	175.11
Total Common Shares Outstanding	517.13	252.38	184.82	178	172.11
Working Capital	4.92	6.09	26.2	44.22	56.18
Book Value Per Share	0.06	0.14	0.25	0.36	0.46
Tangible Book Value	5.02	6.16	26.23	44.35	58.91
Tangible Book Value Per Share	0.01	0.02	0.14	0.25	0.34

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q